IDiyas

For the Inventor, By the Inventor

Dallas, TX, United States of America

Xiaofeng Liu

USPTO Granted Patents = 15 

 

Average Co-Inventor Count = 3.9

ph-index = 13

Forward Citations = 529(Granted Patents)


Location History:

  • Dallas, TX (US) (2011 - 2016)
  • Coppell, TX (US) (2015 - 2024)

Company Filing History:

goldMedal14 out of 61 
 
Reata Pharmaceuticals, Inc.
 patents
silverMedal1 out of 7 
 
Reata Pharmaceuticals Holdings, LLC
 patents

Years Active: 2011-2024

Loading Chart...
Loading Chart...
15 patents (USPTO):
1. 12065464 - 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof (2024-08-20),
2. 11078230 - 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof (2021-08-03),
3. 9701709 - 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof (2017-07-11),
4. 9556222 - A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof (2017-01-31),
5. 9290536 - C4 monomethyl triterpenoid derivatives and methods of use thereof (2016-03-22),
6. 9249089 - Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives (2016-02-02),
7. 9090574 - Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring (2015-07-28),
8. 8993640 - 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof (2015-03-31),
9. RE45325 - Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring (2015-01-05),
10. RE45288 - Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring (2014-12-08),
11. 8440820 - Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring (2013-05-14),
12. 8394967 - Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives (2013-03-12),
13. 8124656 - Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring (2012-02-28),
14. 7943778 - Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives (2011-05-17),
15. 7915402 - Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring (2011-03-29),

Title: Inspiring Innovation: The Impact of Xiaofeng Liu on the Future of Technology

Introduction:

Xiaofeng Liu, a visionary inventor based in Dallas, Texas, is renowned for his passion for innovation and unwavering commitment to excellence. With 14 patents to his name and a relentless pursuit of pushing the boundaries of technology, Liu continues to inspire the next generation of inventors worldwide.

Latest Patents:

Among his latest patents is the groundbreaking invention of "2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof." This compound opens new possibilities in the pharmaceutical industry, showcasing Liu's dedication to pioneering valuable advancements in the field.

Career Highlights:

As a key figure at Reata Pharmaceuticals, Inc., Liu has played a pivotal role in driving forward cutting-edge research and development initiatives. His innovative mindset and strategic approach have led to numerous breakthroughs, solidifying his reputation as a trailblazer in the realm of technology and healthcare.

Collaborations:

Liu's collaborative spirit is exemplified through his joint efforts with esteemed colleagues such as Eric Anderson and Xin Jiang. Together, they have formed a dynamic team that thrives on innovation, creating synergies that have resulted in transformative inventions and patents.

Conclusion:

Xiaofeng Liu's remarkable journey as an inventor underscores the profound impact that passionate individuals can have on shaping the future of technology. His legacy serves as a beacon of inspiration for aspiring inventors, highlighting the importance of perseverance, creativity, and a relentless pursuit of innovation in driving meaningful change in the world.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…